Moore Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-40,000
| Closed | -$4.98M | – | 697 |
|
|
2024
Q4 | $3.34M | Buy |
+40,000
| New | +$3.29M | 0.06% | 279 |
|
|
2024
Q3 | – | Sell |
-25,000
| Closed | -$1.71M | – | 606 |
|
|
2024
Q2 | $1.71M | Hold |
25,000
| – | – | 0.04% | 282 |
|
|
2024
Q1 | $1.73M | Hold |
25,000
| – | – | 0.04% | 273 |
|
|
2023
Q4 | $1.79M | Buy |
+25,000
| New | +$1.44M | 0.04% | 231 |
|
|
2022
Q4 | – | Sell |
-180,185
| Closed | -$8.38M | – | 671 |
|
|
2022
Q3 | $8.38M | Sell |
180,185
-6,121
| -3% | -$320K | 0.23% | 95 |
|
|
2022
Q2 | $10.6M | Buy |
186,306
+107,638
| +137% | +$6.1M | 0.32% | 69 |
|
|
2022
Q1 | $4.81M | Sell |
78,668
-1,632
| -2% | -$84.8K | 0.16% | 213 |
|
|
2021
Q4 | $4.2M | Buy |
+80,300
| New | +$3.37M | 0.11% | 258 |
|
|
2016
Q1 | – | Sell |
-45,000
| Closed | -$2.42M | – | 365 |
|
|
2015
Q4 | $2.42M | Buy |
+45,000
| New | +$2.27M | 0.08% | 192 |
|
Other funds holding ITCI
KIM
HNB